{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:17:06Z","timestamp":1794118626617,"version":"4.8.0"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011950","name":"BMA Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018645","name":"MRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Sleep disturbance is a key symptom of fibromyalgia and a risk factor for chronic widespread pain. This systematic review and meta-analysis aims to assess the effectiveness of pharmacological treatments and cognitive behavioural therapy (CBT) in improving sleep quality in fibromyalgia patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A systematic search of PubMed, MEDLINE, Embase, Cochrane CENTRAL and CINAHL was conducted for randomized controlled trials (RCTs) published up to April 2023. Studies assessing pharmacological or CBT interventions with sleep-related outcomes were included. Data were extracted, and meta-analyses were performed where applicable. Study quality and bias were evaluated using the Cochrane Risk of Bias tool.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Forty-seven RCTs, including 11\u2009094 participants, were reviewed. CBT for insomnia (CBT-I) showed a significant improvement in sleep quality (SMD \u22120.63, 95% CI \u22120.98 to \u22120.27), while CBT for pain (CBT-P) had no significant impact. Pharmacological agents such as pregabalin and sodium oxybate moderately improved sleep, but there was uncertainty around this evidence. Amitriptyline, milnacipran and duloxetine showed no significant benefit for sleep. Study heterogeneity was moderate, and no publication bias was detected.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>CBT-I is a promising treatment for enhancing sleep quality in fibromyalgia. Pharmacological treatments like pregabalin may be beneficial but should be used cautiously due to potential risks. Future research should prioritize trials focusing on sleep as a primary outcome and explore the comparative effectiveness of pharmacological treatments and CBT-I in fibromyalgia. Understanding the mechanisms linking sleep and fibromyalgia will also help guide future therapies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf147","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T10:20:36Z","timestamp":1741947636000},"page":"4495-4516","source":"Crossref","is-referenced-by-count":13,"title":["Treatments for enhancing sleep quality in fibromyalgia: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3672-8290","authenticated-orcid":false,"given":"Anna","family":"Pathak","sequence":"first","affiliation":[{"name":"Department of Medical Sciences, University of Oxford , Oxford,","place":["UK"]},{"name":"Department of General Surgery, NHS Oxford University Hospitals Trust , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2025-5556","authenticated-orcid":false,"given":"Eoin M","family":"Kelleher","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Integrative Neuroimaging, FMRIB Building, John Radcliffe Hospital , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Brennan","sequence":"additional","affiliation":[{"name":"School of Clinical Medicine, University of Cambridge , Cambridge,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-1756","authenticated-orcid":false,"given":"Raj","family":"Amarnani","sequence":"additional","affiliation":[{"name":"Rheumatology Department, University College London Hospitals NHS Foundation Trust , London,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3175-664X","authenticated-orcid":false,"given":"Amanda","family":"Wall","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Integrative Neuroimaging, FMRIB Building, John Radcliffe Hospital , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2754-7387","authenticated-orcid":false,"given":"Robert","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5692-0314","authenticated-orcid":false,"given":"Hopin","family":"Lee","sequence":"additional","affiliation":[{"name":"Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5996-3563","authenticated-orcid":false,"given":"Beth","family":"Fordham","sequence":"additional","affiliation":[{"name":"Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-4208","authenticated-orcid":false,"given":"Anushka","family":"Irani","sequence":"additional","affiliation":[{"name":"Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Oxford,","place":["UK"]},{"name":"Division of Rheumatology, Mayo Clinic Florida , Jacksonville, FL,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"2025080115371911900_keaf147-B1","doi-asserted-by":"crossref","first-page":"itc33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"key":"2025080115371911900_keaf147-B2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025080115371911900_keaf147-B3","doi-asserted-by":"crossref","first-page":"e010364","DOI":"10.1136\/bmjopen-2015-010364","article-title":"Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies","volume":"6","author":"Fayaz","year":"2016","journal-title":"BMJ Open"},{"key":"2025080115371911900_keaf147-B4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2015.56","article-title":"The role of sleep in pain and fibromyalgia","volume":"11","author":"Choy","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"2025080115371911900_keaf147-B5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/24740527.2017.1374820","article-title":"A paradigm change to inform fibromyalgia research priorities by engaging patients and health care professionals","volume":"1","author":"Fitzcharles","year":"2017","journal-title":"Can J Pain"},{"key":"2025080115371911900_keaf147-B6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025080115371911900_keaf147-B7","year":"2021"},{"key":"2025080115371911900_keaf147-B8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7861\/clinmed.2022-0402","article-title":"The diagnosis of fibromyalgia syndrome","volume":"22","author":"Berwick","year":"2022","journal-title":"Clin Med (Lond)"},{"key":"2025080115371911900_keaf147-B9","volume-title":"National Institute For Health and Care Excellence: guidelines. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain","author":"NICE","year":"2021"},{"key":"2025080115371911900_keaf147-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta25090","article-title":"Cognitive-behavioural therapy for a variety of conditions: an overview of systematic reviews and panoramic meta-analysis","volume":"25","author":"Fordham","year":"2021","journal-title":"Health Technol Assess"},{"key":"2025080115371911900_keaf147-B11","first-page":"Ed000142","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080115371911900_keaf147-B12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpain.2018.10.008","article-title":"AAPT diagnostic criteria for fibromyalgia","volume":"20","author":"Arnold","year":"2019","journal-title":"J Pain"},{"key":"2025080115371911900_keaf147-B14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00482-017-0200-7","article-title":"Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles","volume":"31","author":"Eich","year":"2017","journal-title":"Schmerz"},{"key":"2025080115371911900_keaf147-B15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"2025080115371911900_keaf147-B16","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"2025080115371911900_keaf147-B17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780370106","article-title":"Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial","volume":"37","author":"Carette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B18","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780291110","article-title":"A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia","volume":"29","author":"Goldenberg","year":"1986","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B19","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780391111","article-title":"A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia","volume":"39","author":"Goldenberg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/37.12.1279","article-title":"A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder","volume":"37","author":"Hannonen","year":"1998","journal-title":"Br J Rheumatol"},{"key":"2025080115371911900_keaf147-B21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.rbp.2013.01.004","article-title":"Effects of Panax ginseng extract in patients with fibromyalgia: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"35","author":"Braz","year":"2013","journal-title":"Braz J Psychiatry"},{"key":"2025080115371911900_keaf147-B22","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.3899\/jrheum.110194","article-title":"Effects of bedtime very low dose cyclobenzaprine on symptoms and sleep physiology in patients with fibromyalgia syndrome: a double-blind randomized placebo-controlled study","volume":"38","author":"Moldofsky","year":"2011","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B23","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clinthera.2010.08.003","article-title":"Safety and efficacy of esreboxetine in patients with fibromyalgia: an 8-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"32","author":"Arnold","year":"2010","journal-title":"Clin Ther"},{"key":"2025080115371911900_keaf147-B24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/03009749409103725","article-title":"A double-blind placebo controlled trial of fluoxetine in fibromyalgia","volume":"23","author":"Wolfe","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"2025080115371911900_keaf147-B25","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5664\/jcsm.5400","article-title":"The effects of milnacipran on sleep disturbance in fibromyalgia: a randomized, double-blind, placebo-controlled, two-way crossover study","volume":"12","author":"Ahmed","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"2025080115371911900_keaf147-B27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3899\/jrheum.090884","article-title":"A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia","volume":"37","author":"Branco","year":"2010","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B28","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/j.clinthera.2008.11.009","article-title":"Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial","volume":"30","author":"Clauw","year":"2008","journal-title":"Clin Ther"},{"key":"2025080115371911900_keaf147-B29","first-page":"1975","article-title":"Efficacy of milnacipran in patients with fibromyalgia","volume":"32","author":"Gendreau","year":"2005","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3899\/jrheum.080734","article-title":"The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Mease","year":"2009","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B31","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1345\/aph.1R725","article-title":"Efficacy and safety of mirtazapine in fibromyalgia syndrome patients: a randomized placebo-controlled pilot study","volume":"47","author":"Yeephu","year":"2013","journal-title":"Ann Pharmacother"},{"key":"2025080115371911900_keaf147-B32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","article-title":"Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels","volume":"65","author":"Younger","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jpain.2008.03.013","article-title":"A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia","volume":"9","author":"Arnold","year":"2008","journal-title":"J Pain"},{"key":"2025080115371911900_keaf147-B34","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pain.2008.02.027","article-title":"Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin","volume":"136","author":"Crofford","year":"2008","journal-title":"Pain"},{"key":"2025080115371911900_keaf147-B36","first-page":"502","article-title":"A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia","volume":"35","author":"Mease","year":"2008","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B37","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1186\/ar4056","article-title":"A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia","volume":"14","author":"Ohta","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"2025080115371911900_keaf147-B38","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3899\/jrheum.110569","article-title":"An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia","volume":"38","author":"Pauer","year":"2011","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/acr.21595","article-title":"Effect of pregabalin on sleep in patients with fibromyalgia and sleep maintenance disturbance: a randomized, placebo-controlled, 2-way crossover polysomnography study","volume":"64","author":"Roth","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025080115371911900_keaf147-B40","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","article-title":"Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial","volume":"157","author":"Gilron","year":"2016","journal-title":"Pain"},{"key":"2025080115371911900_keaf147-B41","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0b013e318267b8ca","article-title":"Add-on treatment of quetiapine for fibromyalgia: a pilot, randomized, double-blind, placebo-controlled 12-week trial","volume":"32","author":"Potvin","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"2025080115371911900_keaf147-B42","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.3899\/jrheum.091041","article-title":"Effects of sodium oxybate on sleep physiology and sleep\/wake-related symptoms in patients with fibromyalgia syndrome: a double-blind, randomized, placebo-controlled study","volume":"37","author":"Moldofsky","year":"2010","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/art.24142","article-title":"Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial","volume":"60","author":"Russell","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B44","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.pain.2010.12.022","article-title":"Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study","volume":"152","author":"Russell","year":"2011","journal-title":"Pain"},{"key":"2025080115371911900_keaf147-B45","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","article-title":"Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial","volume":"71","author":"Spaeth","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2025080115371911900_keaf147-B46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3109\/03009749109096802","article-title":"Zopiclone in the treatment of sleep abnormalities in fibromyalgia","volume":"20","author":"Drewes","year":"1991","journal-title":"Scand J Rheumatol"},{"key":"2025080115371911900_keaf147-B47","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/1359105310390544","article-title":"Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: a pilot, randomized controlled trial","volume":"16","author":"Mir\u00f3","year":"2011","journal-title":"J Health Psychol"},{"key":"2025080115371911900_keaf147-B48","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1001\/archinte.165.21.2527","article-title":"Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial","volume":"165","author":"Edinger","year":"2005","journal-title":"Arch Int Med"},{"key":"2025080115371911900_keaf147-B49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10865-013-9520-y","article-title":"Cognitive-behavioral therapy for insomnia and sleep hygiene in fibromyalgia: a randomized controlled trial","volume":"37","author":"Mart\u00ednez","year":"2014","journal-title":"J Behav Med"},{"key":"2025080115371911900_keaf147-B50","doi-asserted-by":"crossref","first-page":"zsy234","DOI":"10.1093\/sleep\/zsy234","article-title":"Cognitive behavioral treatments for insomnia and pain in adults with comorbid chronic insomnia and fibromyalgia: clinical outcomes from the SPIN randomized controlled trial","volume":"42","author":"McCrae","year":"2019","journal-title":"Sleep"},{"key":"2025080115371911900_keaf147-B51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10608-017-9875-4","article-title":"Efficacy of combined cognitive-behavioral therapy for insomnia and pain in patients with fibromyalgia: a randomized controlled trial","volume":"42","author":"Lami","year":"2018","journal-title":"Cognit Ther Res"},{"key":"2025080115371911900_keaf147-B52","first-page":"182","article-title":"Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients","volume":"25","author":"Rossini","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"2025080115371911900_keaf147-B53","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780380906","article-title":"Sleep electroencephalography and the clinical response to amitriptyline in patients with fibromyalgia","volume":"38","author":"Carette","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000119138","article-title":"Effect of an antidiencephalon immune serum on pain and sleep in primary fibromyalgia","volume":"30","author":"Kempenaers","year":"1994","journal-title":"Neuropsychobiology"},{"key":"2025080115371911900_keaf147-B55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02030081","article-title":"Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo","volume":"8","author":"Vaer\u00f8y","year":"1989","journal-title":"Clin Rheumatol"},{"key":"2025080115371911900_keaf147-B56","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0304-3959(94)00218-4","article-title":"A randomized controlled trial of citalopram in the treatment of fibromyalgia","volume":"61","author":"N\u00f8rregaard","year":"1995","journal-title":"Pain"},{"key":"2025080115371911900_keaf147-B57","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1002\/hup.622","article-title":"A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia","volume":"19","author":"Vitton","year":"2004","journal-title":"Hum Psychopharmacol."},{"key":"2025080115371911900_keaf147-B58","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0011-393X(99)90008-5","article-title":"Efficacy and tolerability of paroxetine in patients with fibromyalgia syndrome: a single-blind study","volume":"60","author":"Giordano","year":"1999","journal-title":"Curr Ther Res"},{"key":"2025080115371911900_keaf147-B59","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF01452251","article-title":"A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids","volume":"17","author":"Olin","year":"1998","journal-title":"Clin Rheumatol"},{"key":"2025080115371911900_keaf147-B60","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"key":"2025080115371911900_keaf147-B61","first-page":"39","article-title":"Effects of cognitive-behavioral therapy for insomnia on polysomnographic parameters in fibromyalgia patients","volume":"12","author":"S\u00e1nchez","year":"2012","journal-title":"Int J Clin Health Psychol"},{"key":"2025080115371911900_keaf147-B62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpain.2011.11.005","article-title":"Multicomponent cognitive-behavioral group therapy with hypnosis for the treatment of fibromyalgia: long-term outcome","volume":"13","author":"Castel","year":"2012","journal-title":"J Pain"},{"key":"2025080115371911900_keaf147-B63","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00296-016-3473-8","article-title":"The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial","volume":"36","author":"Saral","year":"2016","journal-title":"Rheumatol Int"},{"key":"2025080115371911900_keaf147-B64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1300\/J094v04n03_05","article-title":"A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia","volume":"4","author":"Ginsberg","year":"1996","journal-title":"J Musculoskelet Pain"},{"key":"2025080115371911900_keaf147-B65","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"2025080115371911900_keaf147-B66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025080115371911900_keaf147-B67","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","article-title":"Effects of antidepressants on sleep","volume":"19","author":"Wichniak","year":"2017","journal-title":"Curr Psychiatry Rep"},{"key":"2025080115371911900_keaf147-B68","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2337\/dc12-0656","article-title":"Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life","volume":"35","author":"Boyle","year":"2012","journal-title":"Diabetes Care"},{"key":"2025080115371911900_keaf147-B69","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keq354","article-title":"Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"50","author":"H\u00e4user","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2025080115371911900_keaf147-B70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.sleep.2020.06.028","article-title":"Measurement properties of patient-reported outcome measures used to assess the sleep quality in adults with high prevalence chronic pain conditions: a systematic review","volume":"74","author":"Phelps","year":"2020","journal-title":"Sleep Med"},{"key":"2025080115371911900_keaf147-B71","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-7-54","article-title":"Psychometric properties of a single-item scale to assess sleep quality among individuals with fibromyalgia","volume":"7","author":"Cappelleri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"2025080115371911900_keaf147-B72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/art.23828","article-title":"Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression","volume":"59","author":"Bigatti","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2025080115371911900_keaf147-B73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jpsychores.2006.09.013","article-title":"Exploring the role of sleep and coping in quality of life in fibromyalgia","volume":"62","author":"Theadom","year":"2007","journal-title":"J Psychosom Res"},{"key":"2025080115371911900_keaf147-B74","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/AJP.0000000000000429","article-title":"What determines whether a pain is rated as mild, moderate, or severe? The importance of pain beliefs and pain interference","volume":"33","author":"Jensen","year":"2017","journal-title":"Clin J Pain"},{"key":"2025080115371911900_keaf147-B75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.smrv.2013.07.005","article-title":"A review of the effects of pregabalin on sleep disturbance across multiple clinical conditions","volume":"18","author":"Roth","year":"2014","journal-title":"Sleep Med Rev"},{"key":"2025080115371911900_keaf147-B76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.sleep.2009.01.009","article-title":"The effects of pregabalin on sleep disturbance symptoms among individuals with fibromyalgia syndrome","volume":"10","author":"Russell","year":"2009","journal-title":"Sleep Med"},{"key":"2025080115371911900_keaf147-B77","first-page":"1113","article-title":"Sleep cycles and alpha-delta sleep in fibromyalgia syndrome","volume":"21","author":"Branco","year":"1994","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B78","first-page":"1193","article-title":"Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?","volume":"31","author":"Rizzi","year":"2004","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B79","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"2025080115371911900_keaf147-B80","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","article-title":"Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports","volume":"49","author":"Straube","year":"2010","journal-title":"Rheumatology"},{"key":"2025080115371911900_keaf147-B81","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00023210-200620120-00004","article-title":"\u03b3-Hydroxybutyrate\/sodium oxybate","volume":"20","author":"Pardi","year":"2006","journal-title":"CNS Drugs"},{"key":"2025080115371911900_keaf147-B82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"H\u00e4user","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025080115371911900_keaf147-B83","first-page":"Cd010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025080115371911900_keaf147-B84","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2005.06.031","article-title":"A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder","volume":"119","author":"Arnold","year":"2005","journal-title":"Pain"},{"key":"2025080115371911900_keaf147-B85","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3899\/jrheum.100365","article-title":"Flexible dosed duloxetine in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial","volume":"37","author":"Arnold","year":"2010","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B86","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.1080\/09638288.2021.1954706","article-title":"Cognitive behavioral therapy for insomnia (CBT-i) in patients with fibromyalgia: a systematic review and meta-analysis","volume":"44","author":"Climent-Sanz","year":"2022","journal-title":"Disabil Rehabil"},{"key":"2025080115371911900_keaf147-B87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.sleep.2024.07.031","article-title":"Cognitive behavioral therapy for insomnia in people with chronic musculoskeletal pain. A systematic review and dose-response meta-analysis","volume":"122","author":"Salazar-M\u00e9ndez","year":"2024","journal-title":"Sleep Med"},{"key":"2025080115371911900_keaf147-B88","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Int Med"},{"key":"2025080115371911900_keaf147-B89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.smrv.2019.06.002","article-title":"The impact of cognitive behavioural therapy for insomnia on objective sleep parameters: a meta-analysis and systematic review","volume":"47","author":"Mitchell","year":"2019","journal-title":"Sleep Med Rev"},{"key":"2025080115371911900_keaf147-B90","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.sleep.2020.08.020","article-title":"Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trials","volume":"75","author":"Soh","year":"2020","journal-title":"Sleep Med"},{"key":"2025080115371911900_keaf147-B91","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncprheum0245","article-title":"Cognitive behavioral therapy for fibromyalgia","volume":"2","author":"Bennett","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"2025080115371911900_keaf147-B92","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3899\/jrheum.100104","article-title":"Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome\u2014a systematic review and metaanalysis of randomized controlled trials","volume":"37","author":"Bernardy","year":"2010","journal-title":"J Rheumatol"},{"key":"2025080115371911900_keaf147-B93","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.smrv.2009.10.002","article-title":"Measurement of non-restorative sleep in insomnia: a review of the literature","volume":"14","author":"Vernon","year":"2010","journal-title":"Sleep Med Rev"},{"key":"2025080115371911900_keaf147-B94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1389-9457(00)00098-8","article-title":"Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients","volume":"2","author":"Kushida","year":"2001","journal-title":"Sleep Med"},{"key":"2025080115371911900_keaf147-B95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/smrv.2002.0274","article-title":"Measuring outcomes in randomized clinical trials of insomnia treatments","volume":"7","author":"Morin","year":"2003","journal-title":"Sleep Med Rev"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf147\/62415121\/keaf147.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4495\/62415121\/keaf147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/8\/4495\/62415121\/keaf147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T19:37:33Z","timestamp":1754077053000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/8\/4495\/8078619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":95,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,3,14]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf147","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,3,14]]}}}